2 ASX shares experts think have sold off too much

Which stocks have seen their value plummet even though the underlying businesses have not changed one iota? This pair.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's shocking enough the S&P/ASX 200 Index (ASX: XJO) has sunk 5.8% so far this year.

But with mining and financial shares dragging the index up, there are hundreds of ASX shares that have fallen far more than that.

Some former market darlings, especially ASX growth stocks, have seen their valuations halve, if not worse.

But are we now at a point where some of those businesses have been punished too much? Perhaps the stock price has lost all sense of the company's outlook?  

A couple of experts recently each picked out an ASX share they think are in that position and are ripe to buy right now:

A man in a business suit wearing boxing gloves slumps in the corner of a boxing ring representing the beaten-up Zip share price in recent times

Image source: Getty Images

'Unjustly' sold off

To Montgomery Investment Management portfolio manager Gary Rollo, Symbio Holdings Ltd (ASX: SYM) looks way too cheap at the moment.

The software maker has seen its share price plunge 38.7% this calendar year.

"It's been sold off so hard because the comparators, the overseas players that do what it does, they're at a different stage in their life cycle than the Symbio is," Rollo told a Livewire video.

"So this business has had its valuation regime adjusted, I think unjustly, without reflecting on the fundamentals."

Rollo doesn't detect any change to the business or its outlook compared to before the stock price fall.

"It's a $350 million market cap. It's got $50 million of cash on the balance sheet, so we don't have a capital structure question," he said.

"It's on 8.5 to 9 times EBITDA [earnings before interest, tax, depreciation, and amortisation]… so it doesn't have a valuation question."

Symbio's hot growth opportunity is in Asia and that hasn't diminished.

"But you're not paying for it and so we like the look of that and that's our tip for now." 

'Capital-light, high growth' business

QVG Capital portfolio manager Josh Clark picked Johns Lyng Group Ltd (ASX: JLG) as a current bargain.

Johns Lyng shares have fallen a shocking 37.5% just this month.

"Yeah, absolutely it's been sold off, [from] the $9 range into the mid-$5s or thereabouts, so the valuation's actually starting to look much more compelling."

As a service provider to insurance companies, Johns Lyng was recognised by the market as a star in recent years.

Clark admits that did make the ASX share expensive before May started.

"But they haven't seen a change to their earnings. They're still going to hit their earnings guidance," he said.

"I think part of the sell-off is the market's having a bit of a hissy fit that there's no upgrade near term… Also management has sold some stock."

Clark urged investors to look past the recent share price movements.

"If you focus too much on that, you're missing the forest for the trees," he said.

"It's still a really capital-light, high growth services business. I've said this a lot, but owner, founder-led, which is really important and these guys have just got more irons in the fire than you can count."

Motley Fool contributor Tony Yoo has positions in Johns Lyng Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Johns Lyng Group Limited and Symbio Holdings Limited. The Motley Fool Australia has positions in and has recommended Symbio Holdings Limited. The Motley Fool Australia has recommended Johns Lyng Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy Capstone Copper shares today

A leading analyst expects more outperformance from Capstone Copper’s surging shares. But why?

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Broker Notes

What is this broker's view on Magellan Financial Group after yesterday's disappointing results

Where to next for this funds manager?

Read more »

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

This ASX industrials stock could be set to double according to one broker

This ASX small-cap could be one to keep an eye on.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Broker Notes

What's Bell Potter's updated view on CSL shares?

Will the new tariffs impact CSL according to Bell Potter?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Domino's and Pro Medicus shares

A leading analyst expects Domino’s and Pro Medicus shares to keep underperforming.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Coles, Endeavour, and Rio Tinto shares

The team at Morgans has given its verdict on these popular shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Morgans names two ASX 200 shares to buy and one to sell this week

Let's see which shares Morgans is bullish and bearish on this week.

Read more »